COLLIERS-INTERNATIONAL
Colliers International Group Inc. (NASDAQ and TSX:CIGI), a global leader in commercial real estate services and investment management, announced today its 2018 class of proptech startups for the Colliers Proptech Accelerator powered by Techstars . This program is part of our focus on targeted innovation that will enable us to create solutions, shape technologies and find opportunities to advance our business and accelerate success. In our inaugural class, we have diverse technologies and entrepreneurs, including:
- Solutions across the real estate value chain such as commercial datasets for occupiers and investors; office services and tenant engagement; big data, analytics and artificial intelligence; space as a service; marketplaces and space utilization; and, Smart City and Internet of Things
- Entrepreneurs representing nine cities in seven countries
“Each startup in our Class of 2018 has been carefully selected for investment based on their approach to near-term, value-enhancing opportunities for our clients and professionals as well as longer-term opportunities that, with strong technology platforms, will help us push industry boundaries,” said Jay Hennick, Colliers Chairman & CEO. “At Colliers, our enterprising culture values mentorship and the benefits it can bring to a growing company. Our class will have access to more than 100 Colliers and industry mentors, as part of the Colliers Proptech Accelerator, giving them an exceptional opportunity to test, pilot and grow their companies.”
Over the next 13 weeks, the Class of 2018 will work from the Techstars Accelerator space in Toronto to refine their business plans and gain traction with the market, while accelerating their fundraising strategies and developing Demo Day presentations. Through this process, the startups will work closely with mentors from Colliers and the broader real estate industry, successful startup founders and venture capitalists. At the end of the program, each startup will present to investors and mentors at Demo Day on December 4, 2018.
“Colliers is entrepreneurial and enterprising, which puts us in a unique position to help startups develop innovative, focused, and value-enhancing services for our clients and professionals,” said Dylan Taylor, Colliers President & COO. “Our Proptech Accelerator combines Techstars’ expertise in technology innovation, startups and alumni networks with our real estate expertise and international network.”
Colliers Protech Accelerator Class of 2018 |
A Retail Space (New York, U.S.) A Retail Space finds the perfect location for your business through data. |
Basking (Berlin, Germany) Basking.io is an ROI-driven building automation platform for the flexible office space market. |
Booqed (Hong Kong, China) Booqed is a digital marketplace for flexible space, helping to connect businesses needing places to work, meet or host an event, with landlords seeking to monetize under-utilized space. |
Lane (Toronto, Canada) Lane is the operating system for your building, streamlining building operations on a cloud-based platform you can access anywhere. |
MapYourProperty (Toronto, Canada) MapYourProperty is a Google Maps for Real Estate Land Development, simplifying the planning process to a 3-click solution. |
Propstack (Mumbai, India) Propstack is a data & analytics company that helps predict real estate market trends and enables efficient transactions. |
Raybased (Gothenburg, Sweden) Raybased is the open wireless network for commercial real estate, communicating across all existing electrical systems to monitor, control and optimize functions such as heating, ventilation, lighting and building access. |
RefineRE (Dallas, U.S.) RefineRE leverages real-time market data to provide CRE portfolio intelligence for organizations looking to make smarter, better and faster decisions about buying, selling, leasing, expanding, or downsizing their property footprint. |
SPCE (London, U.K.) In partnership with Experian and the world's top universities, SPCE allows the higher education community to search and pay for campus-specific, student rental properties and accrue a positive credit rating without the need for deposits or joint tenancy liability. |
Upsuite (Denver, U.S.) Where teams go to find coworking spaces. |
About Colliers International Group Inc.
Colliers International Group Inc. (NASDAQ:CIGI) (TSX:CIGI) is a top tier global real estate services and investment management company operating in 69 countries with a workforce of more than 13,000 professionals. Colliers is the fastest-growing publicly listed global real estate services and investment management company, with 2017 corporate revenues of $2.3 billion ($2.7 billion including affiliates). With an enterprising culture and significant employee ownership and control, Colliers professionals provide a full range of services to real estate occupiers, owners and investors worldwide, and through its investment management services platform, has more than $20 billion of assets under management from the world’s most respected institutional real estate investors.
Colliers professionals think differently, share great ideas and offer thoughtful and innovative advice to accelerate the success of its clients. Colliers has been ranked among the top 100 global outsourcing firms by the International Association of Outsourcing Professionals for 13 consecutive years, more than any other real estate services firm. Colliers is ranked the number one property manager in the world by Commercial Property Executive for two years in a row.
Colliers is led by an experienced leadership team with significant equity ownership and a proven record of delivering more than 20% annualized returns for shareholders, over more than 20 years.
For the latest news from Colliers, visit Colliers.com or follow us on Twitter : @Colliers and LinkedIn .
About Techstars
Techstars is the worldwide network that helps entrepreneurs succeed. Techstars founders connect with other entrepreneurs, experts, mentors, alumni, investors, community leaders, and corporations to grow their companies. Techstars operates four divisions: Techstars Startup Programs, Techstars Mentorship-Driven Accelerator Programs, Techstars Corporate Innovation Partnerships, and the Techstars Venture Capital Fund. www.techstars.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20180910005212/en/
Contact:
Colliers International Group Inc. Carolyn Merchant Global Director, PR + Communications Direct: +1 416 324 6405 Carolyn.Merchant@colliers.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 202512.6.2025 13:00:00 CEST | Press release
FDA is expected to notify Innoviva Specialty Therapeutics regarding its decision to conduct an Advisory Committee Meeting in the Day 74 letterIf approved, zoliflodacin would be the first new antibiotic for treating gonorrhea in decades Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), in collaboration with the Global Antibiotic Research & Development Partnership (GARDP), today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the New Drug Application (NDA) for zoliflodacin, an investigational first-in-class, single dose, spiropyrimidinetrione oral antibiotic for the treatment of uncomplicated gonorrhea in adults and pediatric patients 12 years and older. The FDA assigned a target action date of December 15, 2025 under the Prescription Drug User-Fee Act (PDUFA). It is expected the FDA will notify Innoviva Specialty Therapeutics regarding the FDA’s decision to conduct an Advisory Committee Meeting in the Day 74
Supply Chain Leaders to Share Perspective on Tackling Tariffs, Trade, and Disruption During Exclusive Digital Event12.6.2025 13:00:00 CEST | Press release
Experts from Qualcomm, Viant Medical, and Thermo Fisher Scientific join Kinaxis and economic futurist Andrew Busch to share insights on navigating tariff volatility As global trade tensions remain at the forefront of business decision-making,Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, will host technology and life sciences supply chain leaders for a special tariff-focused digital event with economic futurist Andrew Busch on June 17, 2025 at 11:00am eastern. Titled, Tariffs, Trade, and Turbulence: How to Respond to Today’s Supply Chain Challenges, the event is tailored for global business leaders and will offer expert insights on how to navigate today’s volatile trade environment with modern supply chain solutions to build resilient, future-ready supply chains. “We’re witnessing a seismic reshaping of global trade dynamics with leaders needing to decode the economic and geopolitical forces behind tariff policy while being able to anticipate what’s comin
BeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 202512.6.2025 12:00:00 CEST | Press release
Clinical results from next-generation investigational therapies demonstrate potential for deep, durable responses that support the advancement of pivotal studies and future regulatory filingsPhase 1 study of BCL2 inhibitor sonrotoclax plus BRUKINSA® elicited deep responses – 96% ORR in R/R CLL and 79% ORR in R/R MCL patients – with no new safety signals in the latest resultsBTK degrader BGB-16673 shows strong early results in hard-to-treat populations BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will present new clinical data from three cornerstone hematology assets at the European Hematology Association (EHA) Congress. Four oral presentations highlight the promising clinical activity of BeOne’s next-generation BCL2 inhibitor sonrotoclax, BTK protein degrader BGB-16673, and the backbone of our hematology franchise, BTK inhibitor BRUKINSA (zanubrutinib), which has the broadest label globally of any approved BTK inhibitor. These data reinforce
Infobip Named Among Top 75 in Fortune’s Europe’s Most Innovative Companies 202512.6.2025 10:17:00 CEST | Press release
Fortune ranking aligns with Infobip’s innovative efforts in the IT industry and digital infrastructure Global communications platform Infobiphas been recognized among the top 75 companies in Fortune’s inaugural ranking of Europe’s Most Innovative Companies for 2025. It holds the position of number 68, placing it in the top 25% of all listed companies. This distinction reflects Infobip’s ongoing commitment to advancing Europe’s IT sector and digital infrastructure through cutting-edge innovation. The first Fortune Europe’s Most Innovative Companies list, created in collaboration with Statista, evaluated 300 companies from 21 countries and 16 industries based on innovation culture, product development, and process improvements. Infobip is at the forefront of Europe’s digital transformation. Infobip participates in the IPCEI-CIS project, which aims to build the next-generation global communications platform, thereby reinforcing Europe’s competitiveness in the tech sector. Infobip’s involv
Craig Cook appointed Chief Business Officer and Co-founder at ABILITY Neurotech, the Wyss Geneva’s flagship spin-off12.6.2025 09:00:00 CEST | Press release
The Wyss Center for Bio and Neuroengineering proudly announces the appointment of Craig Cook, former Head of Business Development & Licensing at the Center, as Chief Business Officer and Co-founder of ABILITY Neurotech SA, a pioneering spin-off company translating breakthrough brain-computer interface (BCI) technology into clinical impact. During his tenure at the Wyss Center, Craig Cook played a transformative role in establishing a strong business development framework and positioning the organization as a venture builder in neurotechnology. Under his leadership, six breakthrough technologies were successfully spun out into operational startup companies: Clee Medical SA, Brainscape Medical SA, Dataflight Ltd, BrainQuant SA, Aleos Bio SA, and ABILITY Neurotech SA. In parallel, Craig led the onboarding of aligned startups such as Dandelion Science Corp. and dEEGtal Insights SA, strengthening our AI and neurotech ecosystem. He also contributed to Series A investments in two Wyss-affilia
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom